Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Toxicol Lett ; 334: 27-35, 2020 Nov 01.
Article in English | MEDLINE | ID: mdl-32956827

ABSTRACT

Methyl- and propyl- parabens are generally regarded as safe by the U.S Food and Drug Administration and as such are commonly used in personal care products. These parabens have been associated with increased white adipogenesis in vitro and methyl paraben also increased the white adipose mass of mice. Given brown adipose also plays a role in energy balance, we sought to evaluate whether the effects of methyl- and propyl- parabens on white adipocytes extended to brown adipocytes. We challenged white and brown pre-adipocytes at low doses of both parabens (up to 1 µM) during the differentiation process and examined adipogenesis with the ORO assay. The impact of each paraben on glucose uptake and lipolytic activity of adipocytes were measured with a fluorescent glucose analog and enzymatically, respectively. Methyl- and propyl- parabens increased adipogenesis of 3T3-L1 white adipocytes but not brown adipocytes. In white adipocytes, methyl paraben increased glucose uptake and both parabens reduced basal lipolysis. However, in brown adipocytes, parabens had no effect on basal lipolysis and instead attenuated isoproterenol induced lipolysis. These data indicate that methyl- and propyl- parabens target the differentiation and metabolic processes of multiple types of adipocytes in a cell autonomous manner.


Subject(s)
Adipocytes/drug effects , Adipogenesis/drug effects , Parabens/toxicity , Preservatives, Pharmaceutical/toxicity , 3T3-L1 Cells , Adipocytes/metabolism , Adipocytes/pathology , Adipose Tissue, Brown/drug effects , Adipose Tissue, Brown/metabolism , Adipose Tissue, Brown/pathology , Adipose Tissue, White/drug effects , Adipose Tissue, White/metabolism , Adipose Tissue, White/pathology , Animals , Cell Differentiation/drug effects , Cosmetics , Glucose/metabolism , Lipolysis/drug effects , Mice
2.
Environ Res ; 160: 541-546, 2018 01.
Article in English | MEDLINE | ID: mdl-29106953

ABSTRACT

BACKGROUND AND OBJECTIVES: The pesticide metabolite p,p'-DDE has been associated with left ventricular (LV) mass and known risk factors for LV hypertrophy in humans and in experimental models. We hypothesized that the associations of p,p'-DDE with LV hypertrophy risk factors, namely elevated glucose, adiposity and hypertension, mediate the association of p,p'-DDE with LV mass. METHODS: p,p'-DDE was measured in plasma from 70-year-old subjects (n = 988) of the Prospective Study of the Vasculature in Uppsala Seniors (PIVUS). When these subjects were 70-, 75- and 80- years old, LV characteristics were measured by echocardiography, while fasting glucose, body mass index (BMI) and blood pressure were assessed with standard clinical techniques. RESULTS: We found that p,p'-DDE levels were associated with increased fasting glucose, BMI, hypertension and LV mass in separate models adjusted for sex. Structural equation modeling revealed that the association between p,p'-DDE and LV mass was almost entirely mediated by BMI (70%), and also by hypertension (19%). CONCLUSION: The obesogenic effect of p,p'-DDE is a major determinant responsible for the association of p,p'-DDE with LV mass.


Subject(s)
Dichlorodiphenyl Dichloroethylene/toxicity , Environmental Pollutants/toxicity , Heart Ventricles/physiopathology , Hypertrophy, Left Ventricular/epidemiology , Insecticides/toxicity , Obesity/epidemiology , Adiposity/physiology , Aged , Aged, 80 and over , Blood Glucose/analysis , Cohort Studies , Female , Humans , Hypertension/complications , Hypertension/epidemiology , Hypertrophy, Left Ventricular/chemically induced , Male , Obesity/chemically induced , Prevalence , Risk Factors , Sweden/epidemiology
3.
J Dev Orig Health Dis ; 6(3): 242-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25665487

ABSTRACT

Growing evidence indicates that parental smoking is associated with risk of offspring obesity. The purpose of this study was to identify whether parental tobacco smoking during gestation was associated with risk of diabetes mellitus. This is a prospective study of 44- to 54-year-old daughters (n = 1801) born in the Child Health and Development Studies pregnancy cohort between 1959 and 1967. Their mothers resided near Oakland California, were members of the Kaiser Foundation Health Plan and reported parental tobacco smoking during an early pregnancy interview. Daughters reported physician diagnoses of diabetes mellitus and provided blood samples for hemoglobin A1C measurement. Prenatal maternal smoking had a stronger association with daughters' diabetes mellitus risk than prenatal paternal smoking, and the former persisted after adjustment for parental race, diabetes and employment (aRR = 2.4 [95% confidence intervals 1.4-4.1] P < 0.01 and aRR = 1.7 [95% confidence intervals 1.0-3.0] P = 0.05, respectively). Estimates of the effect of parental smoking were unchanged when further adjusted by daughters' birth weight or current body mass index (BMI). Maternal smoking was also significantly associated with self-reported type 2 diabetes diagnosis (2.3 [95% confidence intervals 1.0-5.0] P < 0.05). Having parents who smoked during pregnancy was associated with an increased risk of diabetes mellitus among adult daughters, independent of known risk factors, providing further evidence that prenatal environmental chemical exposures independent of birth weight and current BMI may contribute to adult diabetes mellitus. While other studies seek to confirm our results, caution toward tobacco smoking by or proximal to pregnant women is warranted in diabetes mellitus prevention efforts.


Subject(s)
Diabetes Mellitus/etiology , Obesity/etiology , Prenatal Exposure Delayed Effects , Smoking/adverse effects , Adult , Diabetes Mellitus/epidemiology , Female , Glycated Hemoglobin/metabolism , Humans , Middle Aged , Obesity/epidemiology , Pregnancy , Prospective Studies , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...